Le Lézard
Classified in: Health
Subjects: LAW, HSP, BLK

Health Affairs Drops Racial Fellowship Requirements Following Do No Harm Lawsuit


Declaring Victory Over Discrimination, Do No Harm Voluntarily Drops Suit Against Health Affairs

RICHMOND, Va., Jan. 22, 2024 /PRNewswire/ -- Today, Do No Harm announced it voluntarily dropped a lawsuit against Health Affairs' Health Equity Fellowship for Trainees after Health Affairs eliminated its discriminatory racial eligibility requirements.

In September 2022, Do No Harm filed a lawsuit on the grounds that the Health Affairs fellowship requirement was racially discriminatory against white students: Applicants were only eligible if they "identify as American Indian/Alaskan Native, African American/Black, Asian American, Native Hawaiian and other Pacific Islander, and Hispanic/Latino." While the lawsuit was pending, Health Affairs eliminated the unlawful requirement. As Health Affairs no longer considers race in the fellowship, Do No Harm voluntarily dismissed their lawsuit without prejudice.

"We are pleased that Health Affairs has decided to drop its racially discriminatory requirements for their fellowship," said Do No Harm Chairman Dr. Stanley Goldfarb. "Segregation based on race is illegal and Health Affairs has recognized that. Do No Harm will continue to fight divisive and discriminatory ideology in healthcare wherever we can find it."

The withdrawal filing can be found here: https://donoharmmedicine.org/wp-content/uploads/2024/01/DNH-v.-Health-Affairs-Notice-of-Voluntary-Dismissal.pdf
The original lawsuit can be found here: https://donoharmmedicine.org/2022/09/06/were-suing-health-affairs-for-racial-discrimination/

Do No Harm, established in April 2022, has rapidly gained recognition and made significant strides in its mission to safeguard healthcare from ideological threats. With more than 6,000 members, including doctors, nurses, physicians, and concerned citizens across all 50 states and in 14 countries, DNH has achieved more than 4,900 media hits in top-tier publications and garnered widespread attention through numerous broadcast news appearances.

SOURCE Do No Harm


These press releases may also interest you

at 23:30
Joel's journey to Smile 4 Ever Mexico in Tijuana exemplifies the transformative power of affordable dental care. Struggling with dental problems that affected his quality of life, Joel found a solution in Tijuana, where dental procedures are...

at 21:07
Fellow Aurinia Shareholders, ILJIN SNT Co., Ltd. and its affiliates (collectively, "ILJIN") is a long-term holder of more than 5% of Aurinia Pharmaceuticals Inc. ("Aurinia" or the "Company") and has been supportive of the Company's mission since 2010...

at 20:51
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology and other major...

at 20:30
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. and Alvotech , today announced the availability of SIMLANDI (adalimumab-ryvk) injection in the U.S., as an interchangeable biosimilar to Humira for the treatment of adult...

at 20:05
CUPID is a Phase I safety and dosimetry study of TLX592, Telix's investigational antibody-based targeted alpha therapy for prostate cancer.Establishes proof-of-concept for Telix's proprietary RADmAb® engineered antibody platform, currently under...

at 19:42
The shareholders in Immunovia AB (publ), Reg. No. 556730-4299, are hereby invited to the Annual General Meeting ("AGM") to be held at The Spark, Scheeletorget 1, Medicon Village, in Lund on Wednesday 19 June 2024 at 10 a.m. CEST. Right to...



News published on and distributed by: